The price of Ozempic, which contains the most famous substance for weight loss, will be “much lower”. The announcement was made from the White House itself
The drug Ozempic, in a pharmacy in The Hague, the Netherlands, on July 4, 2025. PHOTO: Utrecht Robin/ABACA / Abaca Press / Profimedia
US President Donald Trump said on Thursday that the price of drug company Novo Nordisk's best-selling weight-loss drug would be cut and that negotiations on price changes would be swift, Reuters reports.
Trump made the announcement at a White House event on fertility treatments and drug prices. Reporters asked him to identify the name of the drug he said earlier in the event would be cheaper.
“I meant Ozempic or – the slimming drug? (…) Their price will be much lower,” said the American leader.
Novo Nordisk markets the drug Ozempic to treat diabetes, while the drug Wegovy is approved for weight loss. Both pharmaceutical products contain the same active ingredient, semaglutide.
Novo, the Denmark-based company that is a world leader in the production of insulin and diabetes drugs, was not immediately available for comment on President Trump's remarks.
Trump previously said that under his administration's plans, the price of the drug would be reduced from $1,300 to $150. Ozempic has a list price of about $1,000 for one month of treatment, but is sold directly by Novo to cash-paying customers for $499 a month.
At the same White House event, Dr. Mehmet Oz, who heads the Centers for Medicare and Medicaid Services, said the agency has yet to finalize price negotiations for GLP-1 drugs, which are used to treat diabetes and obesity.
Novo's Ozempic is one of the drugs the US agency has chosen for price negotiations.
